Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2022-11-09
2024-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Effectiveness of The COVID-19 Vaccine
NCT05766176
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
NCT06055218
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
NCT05621993
Respiratory Virus Metagenomics After COVID-19
NCT05126589
Survey of COVID-19 Infection
NCT05706064
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
A COVID-19 confirmed case is a patient with an acute respiratory illness and RT-PCR confirmation of SARS-CoV-2 infection (i.e. any positive RT-PCR results obtained prior to admission or after enrolment in the study). In case the patient has any inconsistent RT-PCR results (e.g. a positive followed by a negative or a negative followed by a positive result), he/s he/she will be considered as a COVID-19 confirmed case if he/she has at least one positive result during his/her illness under consideration.
no intervention
no intervention
Test-negative control
A COVID-19 negative case is a patient with an acute respiratory illness, in whom all RT-PCR tests are negative for SARS-CoV-2
no intervention
no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 years of age and above
* Residing in the catchment area of the participating hospital
* Admitted to the participating hospital with an acute respiratory illness
* Able and willing to provide a naso- and oro-pharyngeal swab for RT-PCR testing
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coalition for Epidemic Preparedness Innovations
OTHER
Mahidol Oxford Tropical Medicine Research Unit
OTHER
Fudan University
OTHER
University of the Philippines
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacqueline Deen, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
ICHHD, University of the Philippines - National Institutes of Health
Michelle Ylade, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
ICHHD, University of the Philippines - National Institutes of Health
Kristal An C Agrupis, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
ICHHD, University of the Philippines - National Institutes of Health
Maria Vinna Crisostomo, MD
Role: PRINCIPAL_INVESTIGATOR
ICHHD, University of the Philippines - National Institutes of Health
Jedas Veronica Daag, RN, RMT
Role: PRINCIPAL_INVESTIGATOR
ICHHD, University of the Philippines - National Institutes of Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vicente Sotto Memorial Medical Center
Cebu City, Cebu Province, Philippines
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SJREB-2021-103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.